Aeolus Pharmaceuticals, Inc.
AOLS · OTC
9/30/2016 | 9/30/2015 | 9/30/2014 | 9/30/2013 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -33.3% | -67.7% | 145.2% | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | -38.8% | -12.8% | 27.7% | 14.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -157.7% | -84.4% | -0.8% | -68.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -171.4% | -84.5% | -0.8% | -81.7% |
| EPS Diluted | -0.04 | -0.02 | -0.001 | -0.03 |
| % Growth | -100% | -3,233.3% | 98% | – |
| Operating Cash Flow | -$0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | $0 | -$0 |